PrimeRFP SCOUT · Federal Contract Recompete Brief

75N90025F00021F-18 pylarify piflufolastat injection DRUGS FROM — Progenics Pharmaceuticals Inc

Progenics Pharmaceuticals Inc holds $95.0M across 149 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79719D0170. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 25, 2026 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health - Cc
Awarding office
Progenics Pharmaceuticals Inc
Recipient
Sep 25, 2026
PoP end
$611K
Obligated
$430K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Progenics Pharmaceuticals Inc — $90

Contract facts

Federal
Contract number75N90025F00021
Also listed as36F79719D0170-75N90025F00021
AgencyNational Institutes Of Health - Cc
Awarding officeNational Institutes Of Health - Cc
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentProgenics Pharmaceuticals Inc
CAGE34KE9
UEIYLYKVRPCTCR3
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79719D0170
Place of performanceNORTH BILLERICA MA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMar 14, 2025
PoP end (current)Sep 25, 2026
Obligated$611K
Current value$611K
Potential value$430K

PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297] is a federal award for National Institutes Of Health - Cc held by Progenics Pharmaceuticals Inc. Estimated value $430K ($611K obligated). Current period of performance ends Sep 25, 2026. Last award drew 1 bidder. Place of performance: NORTH BILLERICA MA.

PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297]

Recompete timing

Public
Expiring in 35 days

Current PoP ends Sep 25, 2026 (35 days remaining). Agencies typically plan 12–18 months ahead — at 1.1 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Progenics Pharmaceuticals Inc$95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($95.0M) · all agencies
Department of Veterans Affairs (VA)$93.8M · 99%Department of Health and Human Services (HHS)$1.1M · 1%Department of Defense (DOD)$105K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24625N1142
PYLARIFY F-18 INJECTIONS (336)
$1.2M
Aug 31, 2026
36C26126N0023
480 F18 PYLARIFY DOSES POP 1/1/2025 - 12/31/2025
$1.7M
Sep 26, 2026
75N90025F00003
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO. [POTS 25-000073]
$2.1M
Sep 29, 2026
36C26122N0385
PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
$4.5M
Sep 30, 2026
36C24826N0071
PYLARIFY (PIFLUFOLASTAT F 18) INJECTION
$1.2M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N90025F00021?

75N90025F00021 (F-18 pylarify piflufolastat injection DRUGS FROM) is a National Institutes Of Health - Cc award with a potential value of $430K, currently held by Progenics Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N90025F00021?

National Institutes Of Health - Cc awarded 75N90025F00021 to Progenics Pharmaceuticals Inc (potential $430K).

Who is the incumbent on 75N90025F00021?

Progenics Pharmaceuticals Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint. The current period of performance ends Sep 25, 2026.

When does Progenics Pharmaceuticals Inc’s 75N90025F00021 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 25, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N90025F00021